Pituitary surgery represents the first-line treatment for most patients with Cushing’s disease (CD). In the case of surgery failure, additional treatment options are required. Pasireotide has shown favourable results in the first-line treatment of patients with CD, who are not candidates for surgery or in the second-line when surgery has failed. The aim of the current study is to compare the effects of surgery and pasireotide treatment in a cohort of patients with CD, and to evaluate the differences in response rate in terms of hormonal and clinical control, and improvement of metabolic complications.

Guarnotta, V., Ciresi, A., Pizzolanti, G., Giordano, C. (2017). Comparison of clinical and metabolic effects of pasireotide and pituitary surgery in Cushing disease. In Abstract Book SIE 2017 (pp.190-190).

Comparison of clinical and metabolic effects of pasireotide and pituitary surgery in Cushing disease

GUARNOTTA, Valentina;CIRESI, Alessandro;PIZZOLANTI, Giuseppe;GIORDANO, Carla
2017-01-01

Abstract

Pituitary surgery represents the first-line treatment for most patients with Cushing’s disease (CD). In the case of surgery failure, additional treatment options are required. Pasireotide has shown favourable results in the first-line treatment of patients with CD, who are not candidates for surgery or in the second-line when surgery has failed. The aim of the current study is to compare the effects of surgery and pasireotide treatment in a cohort of patients with CD, and to evaluate the differences in response rate in terms of hormonal and clinical control, and improvement of metabolic complications.
6-gen-2017
39° Congresso Nazionale della Società italiana di Endocrinologia
Roma
21-24.06.2017
6-gen-2017
2017
1
A stampa
Guarnotta, V., Ciresi, A., Pizzolanti, G., Giordano, C. (2017). Comparison of clinical and metabolic effects of pasireotide and pituitary surgery in Cushing disease. In Abstract Book SIE 2017 (pp.190-190).
Proceedings (atti dei congressi)
Guarnotta, V.; Ciresi, A.; Pizzolanti, G.; Giordano, C.
File in questo prodotto:
File Dimensione Formato  
Guarnotta - pasireotide.pdf

accesso aperto

Descrizione: abstract
Dimensione 765.09 kB
Formato Adobe PDF
765.09 kB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/10447/236204
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus ND
  • ???jsp.display-item.citation.isi??? ND
social impact